These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2947132)

  • 1. [Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma].
    Bataille R; Grenier J
    Presse Med; 1986 Oct; 15(34):1723-5. PubMed ID: 2947132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
    Avilés A; Zepeda G; Guzmán R; Talavera A; García EL; Díaz-Maqueo JC
    Rev Invest Clin; 1992; 44(2):215-20. PubMed ID: 1439309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.
    Garewal H; Durie BG; Kyle RA; Finley P; Bower B; Serokman R
    J Clin Oncol; 1984 Jan; 2(1):51-7. PubMed ID: 6366146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2 microglobulin in multiple myeloma.
    Alexanian R; Barlogie B; Fritsche H
    Am J Hematol; 1985 Dec; 20(4):345-51. PubMed ID: 3907332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
    Cuzick J; Cooper EH; MacLennan IC
    Br J Cancer; 1985 Jul; 52(1):1-6. PubMed ID: 3893505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
    Kraj M; Maj S; Pogłód R; Rostkowska J
    Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
    Bataille R; Grenier J; Sany J
    Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.
    Scarffe JH; Anderson H; Palmer MK; Crowther D
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1361-4. PubMed ID: 6357802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.
    Durie BG; Stock-Novack D; Salmon SE; Finley P; Beckord J; Crowley J; Coltman CA
    Blood; 1990 Feb; 75(4):823-30. PubMed ID: 2405920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma: beta-2-microglobulin is not a useful follow-up parameter.
    Boccadoro M; Omedè P; Frieri R; Battaglio S; Gallone G; Massaia M; Redoglia V; Pileri A
    Acta Haematol; 1989; 82(3):122-5. PubMed ID: 2510433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 May; 37(5):479-87. PubMed ID: 1842146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of asymptomatic multiple myeloma.
    Alexanian R; Barlogie B; Dixon D
    Arch Intern Med; 1988 Sep; 148(9):1963-5. PubMed ID: 2458080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
    Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
    Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum beta-2-microglobulin (beta 2m) in myeloma: toward a simple prognostic stratification using beta 2M and acute-phase proteins?
    Bataille R; Klein B
    Blood; 1991 Apr; 77(7):1616-7. PubMed ID: 1706956
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients.
    Bataille R; Grenier J; Sany J
    Blood; 1984 Feb; 63(2):468-76. PubMed ID: 6362753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase.
    Diem H; Fateh-Moghadam A; Lamerz R
    Clin Investig; 1993 Nov; 71(11):918-23. PubMed ID: 8312685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and staging in multiple myeloma: a reappraisal.
    Bataille R; Durie BG; Grenier J; Sany J
    J Clin Oncol; 1986 Jan; 4(1):80-7. PubMed ID: 3510284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.